NasdaqCM - Delayed Quote • USD
Aeterna Zentaris Inc. (AEZS)
At close: April 19 at 4:00 PM EDT
Earnings Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | -0.81 | -0.82 | -3.37 | 0 |
| Low Estimate | -0.81 | -0.82 | -3.37 | 0 |
| High Estimate | -0.81 | -0.82 | -3.37 | 0 |
| Year Ago EPS | -0.88 | -0.52 | -3.41 | -3.37 |
Revenue Estimate
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| No. of Analysts | 1 | 1 | 1 | -- |
| Avg. Estimate | 1.1M | 1.1M | 4.3M | -- |
| Low Estimate | 1.1M | 1.1M | 4.3M | -- |
| High Estimate | 1.1M | 1.1M | 4.3M | -- |
| Year Ago Sales | 2.13M | 2.25M | 4.5M | 4.3M |
| Sales Growth (year/est) | -48.30% | -51.00% | -4.40% | -- |
Earnings History
| CURRENCY IN USD | 3/31/2023 | 6/30/2023 | 9/30/2023 | 12/31/2023 |
|---|---|---|---|---|
| EPS Est. | -1.07 | -0.87 | -0.61 | -0.97 |
| EPS Actual | -0.88 | -0.52 | -0.85 | -1.16 |
| Difference | 0.19 | 0.35 | -0.24 | -0.19 |
| Surprise % | 17.80% | 40.20% | -39.30% | -19.60% |
EPS Trend
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Current Estimate | -0.81 | -0.82 | -3.37 | 0 |
| 7 Days Ago | -0.81 | -0.82 | -3.37 | 0 |
| 30 Days Ago | -0.81 | -0.82 | -3.37 | 0 |
| 60 Days Ago | -0.81 | -0.82 | -3.37 | 0 |
| 90 Days Ago | -0.81 | -0.82 | -3.37 | 0 |
EPS Revisions
| CURRENCY IN USD | Current Qtr. (Mar 2024) | Next Qtr. (Jun 2024) | Current Year (2024) | Next Year (2025) |
|---|---|---|---|---|
| Up Last 7 Days | -- | -- | -- | -- |
| Up Last 30 Days | -- | -- | -- | -- |
| Down Last 7 Days | -- | -- | -- | -- |
| Down Last 30 Days | -- | -- | -- | -- |
Growth Estimates
| CURRENCY IN USD | AEZS | Industry | Sector | S&P 500 |
|---|---|---|---|---|
| Current Qtr. | 8.00% | -- | -- | 1.60% |
| Next Qtr. | -57.70% | -- | -- | 10.50% |
| Current Year | 1.20% | -- | -- | 5.20% |
| Next Year | -- | -- | -- | 13.30% |
| Next 5 Years (per annum) | -- | -- | -- | 11.22% |
| Past 5 Years (per annum) | -- | -- | -- | -- |
Research Analysis
Analyst Price Targets
Fair Value
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Analyst Recommendations
- Strong Buy
- Buy
- Hold
- Underperform
- Sell
Earnings
Related Tickers
CZO.V Ceapro Inc.
0.2450
-2.00%
CRPOF Ceapro Inc.
0.1771
0.00%
MRKR Marker Therapeutics, Inc.
4.1400
+0.98%
VYNE VYNE Therapeutics Inc.
2.2500
-2.17%
CMMB Chemomab Therapeutics Ltd.
0.6800
-2.86%
DRTS Alpha Tau Medical Ltd.
2.5600
-3.76%
KTTA Pasithea Therapeutics Corp.
7.11
-0.14%
VTVT vTv Therapeutics Inc.
24.04
-3.80%
BNTC Benitec Biopharma Inc.
6.99
+2.49%
SABS SAB Biotherapeutics, Inc.
4.2900
-2.72%